Journal of cardiovascular pharmacology

Keyphrases

Publications

volume 84, number 1, 2024

Chenchen Zhou, Yanxia Zhong, Yun Chu, Renyu Chen, Yurou Wang, Yingfang Zheng, Hongkai Dai, Chengye Zhan, Aini Xie, Jinlong Luo
Glutathione S-Transferase α4 Alleviates Hyperlipidemia-Induced Vascular Neointimal Hyperplasia in Arteriovenous Grafts via Inhibiting Endoplasmic Reticulum Stress. Journal of cardiovascular pharmacology 84 (1) (2024)
Tzu-Hao Liu, Rebecca Jen-Ling Hsieh, Hsin-Hung Chen, Tzu-Jiun Kuo, Jui-Chen Lee, Wen-Hsien Lu
Propranolol Alleviates Cardiac Injury After Acute Catecholamine Infusion Through p38-MAPK Pathways. Journal of cardiovascular pharmacology 84 (1) (2024)
Chenxin Zeng, Jiangfeng Wu, Junming Li
Pyruvate Kinase M2: A Potential Regulator of Cardiac Injury Through Glycolytic and Non-glycolytic Pathways. Journal of cardiovascular pharmacology 84 (1) (2024)
Ye-Wei Huang, Fang Luo, Meng Zhang, Litian Wang, WenLuer Meng, Dandan Hu, Jinbo Yang, Jun Sheng, Xuanjun Wang
20( S )-Protopanaxatriol Improves Atherosclerosis by Inhibiting Low-Density Lipoprotein Receptor Degradation in ApoE KO Mice. Journal of cardiovascular pharmacology 84 (1) (2024)
Xuefang Zhang, Gang Sun, Zhiquan Li, Weidong Gao, Wenfeng Tan, Jinxue Liu, Bin Zhang, Juan Wu, Rong Chen, Xiu Juan Li, Gaoxing Zhang
Effectiveness of Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Acute Myocardial Infarction With or Without Type 2 Diabetes: A Systematic Review and Meta-analysis. Journal of cardiovascular pharmacology 84 (1) (2024)
Martyna Sikorska, Jakub Chmiel, Elzbieta Papuga-Szela, Elzbieta Broniatowska, Anetta Undas
Apixaban Versus Vitamin K Antagonists in Patients With Antiphospholipid Syndrome: A Cohort Study. Journal of cardiovascular pharmacology 84 (1) (2024)
Xuefang Zhang, Gang Sun, Zhiquan Li, Weidong Gao, Wenfeng Tan, Jinxue Liu, Bin Zhang, Juan Wu, Rong Chen, Xiu Juan Li, Gaoxing Zhang
Effectiveness of Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Acute Myocardial Infarction With or Without Type 2 Diabetes: A Systematic Review and Meta-analysis. Journal of cardiovascular pharmacology 84 (1) (2024)
Ye-Wei Huang, Fang Luo, Meng Zhang, Litian Wang, WenLuer Meng, Dandan Hu, Jinbo Yang, Jun Sheng, Xuanjun Wang
20( S )-Protopanaxatriol Improves Atherosclerosis by Inhibiting Low-Density Lipoprotein Receptor Degradation in ApoE KO Mice. Journal of cardiovascular pharmacology 84 (1) (2024)
Mattia Galli, Sebastiano Sciarretta, Giacomo Frati, Giuseppe Biondi Zoccai
Reevaluating Anticoagulation in Antiphospholipid Syndrome: The Role of Apixaban in the Current Treatment Paradigm. Journal of cardiovascular pharmacology 84 (1) (2024)
Xue Zhang, Zhongsu Wang, Le Zhang, Xia Zhao, Yi Han
Comparative Effectiveness and Safety of Intermittent, Repeated, or Continuous Use of Levosimendan, Milrinone, or Dobutamine in Patients With Advanced Heart Failure: A Network and Single-Arm Meta-analysis. Journal of cardiovascular pharmacology 84 (1) (2024)
Paschalis Karakasis, Dimitrios Patoulias, George Giannakoulas, Nikolaos Fragakis
Are We Ready for Expanding the Use of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Acute Myocardial Infarction? Journal of cardiovascular pharmacology 84 (1) (2024)
Paschalis Karakasis, Dimitrios Patoulias, George Giannakoulas, Nikolaos Fragakis
Are We Ready for Expanding the Use of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Acute Myocardial Infarction? Journal of cardiovascular pharmacology 84 (1) (2024)
Chenchen Zhou, Yanxia Zhong, Yun Chu, Renyu Chen, Yurou Wang, Yingfang Zheng, Hongkai Dai, Chengye Zhan, Aini Xie, Jinlong Luo
Glutathione S-Transferase α4 Alleviates Hyperlipidemia-Induced Vascular Neointimal Hyperplasia in Arteriovenous Grafts via Inhibiting Endoplasmic Reticulum Stress. Journal of cardiovascular pharmacology 84 (1) (2024)
Martyna Sikorska, Jakub Chmiel, Elzbieta Papuga-Szela, Elzbieta Broniatowska, Anetta Undas
Apixaban Versus Vitamin K Antagonists in Patients With Antiphospholipid Syndrome: A Cohort Study. Journal of cardiovascular pharmacology 84 (1) (2024)
Tzu-Hao Liu, Rebecca Jen-Ling Hsieh, Hsin-Hung Chen, Tzu-Jiun Kuo, Jui-Chen Lee, Wen-Hsien Lu
Propranolol Alleviates Cardiac Injury After Acute Catecholamine Infusion Through p38-MAPK Pathways. Journal of cardiovascular pharmacology 84 (1) (2024)
Lu Gao, Qi Wang, Min-Yi Li, Meng-Meng Zhang, Bin Wang, Tai-Wei Dong, Pei-Feng Wei, Min Li
A Mechanism for the Treatment of Cardiovascular and Renal Disease: TRPV1 and TRPA1. Journal of cardiovascular pharmacology 84 (1) (2024)
Chenxin Zeng, Jiangfeng Wu, Junming Li
Pyruvate Kinase M2: A Potential Regulator of Cardiac Injury Through Glycolytic and Non-glycolytic Pathways. Journal of cardiovascular pharmacology 84 (1) (2024)
Ye-Wei Huang, Fang Luo, Meng Zhang, Litian Wang, WenLuer Meng, Dandan Hu, Jinbo Yang, Jun Sheng, Xuanjun Wang
20( S )-Protopanaxatriol Improves Atherosclerosis by Inhibiting Low-Density Lipoprotein Receptor Degradation in ApoE KO Mice. Journal of cardiovascular pharmacology 84 (1) (2024)
Alexandre Luz de Castro, Vanessa Duarte Ortiz, Alexandre R Hickmann, Denise Santos Lacerda, Patrick Türck, Cristina Campos Carraro, Schauana Freitas, Adriane Bello Klein, Valquiria Bassani, Alex Sander da Rosa Araujo
Effects of Pterostilbene on Heart and Lung Oxidative Stress Parameters in 2 Experimental Models of Cardiovascular Disease: Myocardial Infarction and Pulmonary Arterial Hypertension. Journal of cardiovascular pharmacology 84 (1) (2024)
Chenxin Zeng, Jiangfeng Wu, Junming Li
Pyruvate Kinase M2: A Potential Regulator of Cardiac Injury Through Glycolytic and Non-glycolytic Pathways. Journal of cardiovascular pharmacology 84 (1) (2024)
Shuai Jiang, Yitong Li, Jiali Zhang, Wenhui Jia, Yizheng Zheng, Zhiping Jia, Chenming Yu, Yi Kong
Dual Inhibition of Factor XIIa and Factor XIa Produces a Synergistic Anticoagulant Effect. Journal of cardiovascular pharmacology 84 (1) (2024)
Xue Zhang, Zhongsu Wang, Le Zhang, Xia Zhao, Yi Han
Comparative Effectiveness and Safety of Intermittent, Repeated, or Continuous Use of Levosimendan, Milrinone, or Dobutamine in Patients With Advanced Heart Failure: A Network and Single-Arm Meta-analysis. Journal of cardiovascular pharmacology 84 (1) (2024)
Chenxin Zeng, Jiangfeng Wu, Junming Li
Pyruvate Kinase M2: A Potential Regulator of Cardiac Injury Through Glycolytic and Non-glycolytic Pathways. Journal of cardiovascular pharmacology 84 (1) (2024)
Yin Feng Chen, Nan Nan Liu, Jing Yun Wang, Jing Shu Sun, Yi Xiao Wang, Hai Ying Jiang, Wei Wei Zhou, Zu Lu Wang, Ming Liang
Use of 3D Echocardiography Facilitates Analysis of Thrombolytic Efficacy in Patients With Persistent Atrial Fibrillation. Journal of cardiovascular pharmacology 84 (1) (2024)
Piero Pollesello
Repetitive Treatments With Inotropes in Advanced Heart Failure. Journal of cardiovascular pharmacology 84 (1) (2024)

volume 84, number 2, 2024

Dave L Dixon, Salvatore Carbone
Is Metformin Cardioprotective? A New Piece to the Puzzle. Journal of cardiovascular pharmacology 84 (2) (2024)
Hao-Wei Deng, Zi-Ming Ye, Rui-Ting Hu, Chao Qin
The Role of Long Noncoding RNAs in Vascular Smooth Muscle Cell Phenotype and the Pathogenesis of Cardiovascular and Cerebrovascular Aneurysms. Journal of cardiovascular pharmacology 84 (2) (2024)
Die Hu, Donglu Qin, Jie Kuang, Yang Yang, Shuwei Weng, Jin Chen, Sha Wu, Shuai Wang, Ling Mao, Daoquang Peng, Bilian Yu
Metformin-Induced Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition Further Decreases Low-Density Lipoprotein Cholesterol Following Statin Treatment in Patients With Coronary Artery Disease and Without Diabetes. Journal of cardiovascular pharmacology 84 (2) (2024)
Marco Giuseppe Del Buono, Giulia La Vecchia, Alessia D'Aiello, Daniela Pedicino, Gaetano Pinnacchio, Lorenzo Genuardi, Rocco Antonio Montone, Gianluigi Saponara, Antonio Di Renzo, Cristina Conte, Francesco Cribari, Francesco Moroni, Simone Filomia, Mattia Brecciaroli, Cristina Aurigemma, Giovanna Liuzzo, Carlo Trani, Francesco Burzotta, Tommaso Sanna
Clinical Characteristics, Management, and Outcomes in Cardiogenic Shock: Insights From a High-Volume Italian Cardiac Intensive Care Unit. Journal of cardiovascular pharmacology 84 (2) (2024)
Marco Giuseppe Del Buono, Giulia La Vecchia, Alessia D'Aiello, Daniela Pedicino, Gaetano Pinnacchio, Lorenzo Genuardi, Rocco Antonio Montone, Gianluigi Saponara, Antonio Di Renzo, Cristina Conte, Francesco Cribari, Francesco Moroni, Simone Filomia, Mattia Brecciaroli, Cristina Aurigemma, Giovanna Liuzzo, Carlo Trani, Francesco Burzotta, Tommaso Sanna
Clinical Characteristics, Management, and Outcomes in Cardiogenic Shock: Insights From a High-Volume Italian Cardiac Intensive Care Unit. Journal of cardiovascular pharmacology 84 (2) (2024)
Cheng Jiang, Shengbao Wang, Cunbao Wang, Gang Chen, Jing Xu, Chongge You
Mesenchymal Stem Cells Alleviate Mouse Sepsis-Induced Cardiomyopathy by Inhibiting the NR1D2/LCN2 Pathway. Journal of cardiovascular pharmacology 84 (2) (2024)
Bingyan Hou, Dan Yu, Haotian Bai, Xiaowei Du
Research Progress of miRNA in Heart Failure: Prediction and Treatment. Journal of cardiovascular pharmacology 84 (2) (2024)
Jian Zhang, Yao Lu, Yihui Shen, Hui Zhang, Yuchen Xu, Xuejun Wang, Yifan Chen, Xiaozhen He, Hao Lu, Leilei Cheng
Spock2 Functions as a Key Time-Series Gene of Endothelial Cells in Sepsis-Induced Cardiomyopathy. Journal of cardiovascular pharmacology 84 (2) (2024)
Marco Giuseppe Del Buono, Giulia La Vecchia, Alessia D'Aiello, Daniela Pedicino, Gaetano Pinnacchio, Lorenzo Genuardi, Rocco Antonio Montone, Gianluigi Saponara, Antonio Di Renzo, Cristina Conte, Francesco Cribari, Francesco Moroni, Simone Filomia, Mattia Brecciaroli, Cristina Aurigemma, Giovanna Liuzzo, Carlo Trani, Francesco Burzotta, Tommaso Sanna
Clinical Characteristics, Management, and Outcomes in Cardiogenic Shock: Insights From a High-Volume Italian Cardiac Intensive Care Unit. Journal of cardiovascular pharmacology 84 (2) (2024)
Rui-Yu Wang, Ming-Gui Wang, Han-Zhang Tang, Hui Du, Yue Luo, Quan Li, Xiao-Hong Zhang, Jing Fu, Chuan-Zhu Lv
The Protective Effects of Ruscogenin Against Lipopolysaccharide-Induced Myocardial Injury in Septic Mice. Journal of cardiovascular pharmacology 84 (2) (2024)
Ying Zou, Xin Liu, Yiqian Hu, Cui Zhang, Bo Shen, Bo Yang
Inhibition of α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptors Ameliorates Atrial Inflammation and Vulnerability to Atrial Fibrillation in Rats with Anxiety Disorders. Journal of cardiovascular pharmacology 84 (2) (2024)
Roko P A Nikolic, Mansimran K Virk, Katherine A Buhler, Karen H Costenbader, May Y Choi, Brittany N Weber
Hydroxychloroquine and Chloroquine-Induced Cardiac Arrhythmias and Sudden Cardiac Death in Patients With Systemic Autoimmune Rheumatic Diseases: A Systematic Review and Meta-Analysis. Journal of cardiovascular pharmacology 84 (2) (2024)
Riccardo Barbiero, Benedetta Pennella, Aldo Bonaventura
The Long-Standing Search for Albumin Placement in Acute Heart Failure. Journal of cardiovascular pharmacology 84 (2) (2024)
Olivia M O'Brien, Sarah M Tremble, Ari Kropf, Marilyn J Cipolla
Thrombin in Pregnancy and Preeclampsia: Expression, Localization, and Vasoactivity in Brain and Microvessels From Rats. Journal of cardiovascular pharmacology 84 (2) (2024)
Vincenzo Russo, Dario Fabiani, Egidio Imbalzano, Mario De Michele, Paola Castellano, Iginio Colaiori, Valentina Parisi, Antonello D'Andrea, Emilio Attena
Clinical Performance and Persistence on Dual Pathway Inhibition with Rivaroxaban and Aspirin in Real-World Setting. Journal of cardiovascular pharmacology 84 (2) (2024)
Francisco José Romeo
Dual Pathway Inhibition in Stable Cardiovascular Disease: It Takes Two to Tango! Journal of cardiovascular pharmacology 84 (2) (2024)
Lea Haverbeck Simon, Jacob Garritson, Nicholas Pullen, Reid Hayward
Exercise Preconditioning Preserves Cardiac Function and Enhances Cardiac Recovery Following Dobutamine Stimulation in Doxorubicin-Treated Rat Hearts. Journal of cardiovascular pharmacology 84 (2) (2024)
Michele Golino, Pietro-Enea Lazzerini
Hydroxychloroquine, Chloroquine, and Arrhythmic Risk in Systemic Autoimmune Diseases: Focus More on the Patient and You Will Keep the Rhythm! Journal of cardiovascular pharmacology 84 (2) (2024)
Olivia M O'Brien, Sarah M Tremble, Ari Kropf, Marilyn J Cipolla
Thrombin in Pregnancy and Preeclampsia: Expression, Localization, and Vasoactivity in Brain and Microvessels From Rats. Journal of cardiovascular pharmacology 84 (2) (2024)
Yana Kakzanov, Ziv Sevilya, Alexander Goldman, Michal Cipok, Vera Hershkovitz, Gabriel Bryk, Eli I Lev
The Effect of SGLT2 Inhibitor Therapy on Endothelial Progenitor Cell Function in Patients With Heart Failure. Journal of cardiovascular pharmacology 84 (2) (2024)

volume 84, number 3, 2024

Jouko M Levijoki, Matti Kivikko, Piero Pollesello
Levosimendan as an Antidote in Experimental Calcium Channel Blocker Intoxication. Journal of cardiovascular pharmacology 84 (3) (2024)
Yi-Yi Li, Xin-Jing Zhong, Jun-Ting Luo, Chun-Mei Zeng, He Li, Li-Qiu Zhong, Guang-Xin Zou
Fondaparinux Sodium for Anticoagulant Therapy After Primary Percutaneous Coronary Intervention: A Single-Center Randomized Trial in China. Journal of cardiovascular pharmacology 84 (3) (2024)
Fawzi A Babiker, Aisha Al-Kouh
Immunoglobulin-Mediated Cardiac Protection From Ischemia/Reperfusion Injury in Diabetic Rats Is Associated With Endothelial Nitric Oxide Synthase/Glucose Transporter-4 Signaling Pathway. Journal of cardiovascular pharmacology 84 (3) (2024)
Hui-Min Huang, Feng-Ying Ran, Jun Chen, Yu-Si Shen, Ning Liu, Xue-Qiang Jiang, Yue Wang
Outcomes of Ticagrelor Versus High-dose Clopidogrel in CYP2C19 Intermediate Metabolizer Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndromes. Journal of cardiovascular pharmacology 84 (3) (2024)
Yaping Zhao, Li Wang, Yu Huang, Paul C Evans, Peter J Little, Xiaoyu Tian, Jianping Weng, Suowen Xu
Anthocyanins in Vascular Health and Disease: Mechanisms of Action and Therapeutic Potential. Journal of cardiovascular pharmacology 84 (3) (2024)